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Super paramagnetic iron oxide nanometre scale particles have 
been utilised as contrast agents to image staked target binding 
oligonucleotide arrays using MRI to correlate the signal intensity 
and T2* relaxation times in different NMR fluids. 15 
Microarraya are a high-capacity technology that facilitates the 
simultaneous monitoring of expression of thousands of genes 
or proteins,1-3 and often constitute a critical start-point for 
further analyses. Commonly, assays involve the detection of 
interactions between hybridised probes and a target sample 20 
via fluorescent labelling or radioisotope markers.4 Other 
techniques including Kelvin micro-probing5 and matrix-
assisted laser desorption/ionisation mass spectrometry have 
also been demonstrated.6 In molecular biology, the use of 
multiple probes, typically consisting of messenger RNA or 25 
complementary DNA oligonucleotides (cDNA), can be used 
to identify useful diagnostic biomarkers for diseases including 
cancers.7 
There are several methods that can be used for the 
hybridisation of probes to a substrate;8-10 however, robotic 30 
spotting and photolithography are by far the most common. In 
spotted microarrays, products from a polymerase chain 
reaction are printed using a robot, or alternatively with a 
method devised from those used in ink-jet printing.8 
Photolithographic microarrays involve the stepwise addition 35 
of, for example, nucleotides by selective protection and de-
protection of localised areas of substrate.9, 10 In addition to the 
detection of gene products, these technologies can be applied 
to protein arrays and chemical sensors.11 Both of these 
techniques implement the use of fluorescent markers on 40 
probes to detect hybridised interactions on the array.12  
 The present fluorescent systems have several drawbacks, 
for example, non-specific binding and cross-reactivity can 
result in false-positive and false-negative data in complex 
biological samples, resulting in the requirement for further 45 
analyses by, for example, quantitative real-time polymerase 
chain reaction.13,14 Furthermore, the sensitivity of fluorescent 
detection is reduced by processes such as quenching, resulting 
in the need for further resources to be used in order to 
optimise the experimental data.15 The potential scope for 50 
detecting specific entities of interest within complex samples 
is limited further by the presence of spectral overlap. This 
limits the number of fluorophores that can be utilised within 
an experiment, which in turn dictates the ultimate maximum 
throughput. Additional problems associated with the use of 55 
spotted arrays include the presence of irregular shaped or 
sized spots, the use of porous substrates and the presence of 
contaminating material, all of which can interfere with 
fluorescence measurements. Herein, an alternative detection 
system using magnetic resonance imaging (MRI) is 60 
demonstrated that uses insertion of the microarray in a nuclear 
magnetic resonance (NMR) imaging fluid and which does not 
depend on fluorescent probes. 
 
Scheme 1 Probe-target binding 65 
 MRI is conventionally used to non-invasively image major 
organs including the heart and lungs, providing evidence of 
structural and functional changes that may be associated with 
disease. It involves the use of magnetic field gradients to 
determine an NMR signal from localised volumes of a sample. 70 
The measurement of NMR relaxation times (T1, T2 and T2*) 
and subsequent frequency analyses allows the reconstruction 
of complex three-dimensional images. Superconducting 
magnets are conventionally utilised in MRI scanners; 
however, instruments that utilise permanent magnets to 75 
unilaterally image samples placed above a homogenous 
magnetic field have recently been developed,16 thereby 
opening up the sample accessibility in this versatile imaging 
technology.17 
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 By substituting the habitual fluorescent markers used in 
traditional microarray technologies with an MRI contrast 
agent, namely super-paramagnetic iron oxide (SPIO), a novel 
MRI readable DNA array system has been developed.18 The 
interaction between probe and target cDNA strands can be 5 
monitored and imaged using MRI to detect localised changes 
in the NMR signal coming from a fluid saturating the system. 
The addition of a SPIO marker to a complementary cDNA 
strand results in the enhancement of T2* relaxation times via 
the increased dephasing efficiency of the surrounding fluid’s 10 
protons.  
 The preparation of the MRI readable DNA arrays is 
summarised in Scheme 1. Typically two target 
oligonucleotides were immobilised onto a glass surface via a 
silylated N-malimidoalylamide bridge into a 13×6 array. The 15 
glass microscope slides (76×26 mm) were prepared by etching 
78 circular spots (diameter 2 mm) into a 13×6 arrangement 
with separations of 2 mm using a Hobart’s laser cutter linked 
to corelDRAW software. Slides were then cleaned by being 
immersed in a methanolic solution of sodium hydroxide 20 
overnight, rinsed in distilled water, immersed in HCl (37 %) 
for 2 hours, further rinsed in water and stored in diethyl ether. 
Freshly prepared N-(3-triethoxysilylpropyl)-6-(N-maleimido)-
hexanamide, TPMH, in acetonitrile (0.01 M, 10 µL)19 was 
manually spotted onto the dried template surface using an 25 
automated pipette and irradiated for 3 × 15 seconds in a 
domestic microwave oven (800 W).  
 
Fig. 1 Colour-coded MRI images of our system saturated with (a) water 
and (b) silicone oil (MRI parameters: TE = 30 ms, TEeff = 1.905 s, 16 30 
averages, slice thickness = 0.7 mm, imaging time = 61 s, RARE factor = 
number of lines = 128). Misregistration of the spots between the two 
images is due to the different sample’s relative position when the fluids 
were changed. Although MR images demonstrate alternatively ‘labelled’ 
spots, the image with the fluid exploiting the highest self-diffusion 35 
coefficient (water) clearly exhibits superior contrast. 
 Complementary and non-complementary oligonucleotides 
(5’-GTCCAGCAGACCTTCTCCTCAGGAG-3’) and (5’-
CTCCTGAGGAGAAGGTCTGCTGGAC-3’), respectively, 
were modified with the incorporation of a terminal thiol group 40 
linked to the 5’ end via a hexane spacer (Sigma-Genosys)‡ 
were spotted (1 µL) on top of the pre-spotted TPMH in an 
alternating arrangement. The array was then incubated at 37 
°C in a humidified chamber for 1 hour and washed with water. 
 Unmodified 5’-CTCCTGAGGAGAAGGTCTGCTGGAC-45 
3’ oligonucleotide was labelled with dextran-coated SPIO,20 
being added to the freshly prepared oligonucleotide array and 
left to hydrolyze in a humid chamber for 24 hours. The arrays 
were subsequently washed with water and arranged into a 
fluid filled stacked microscope slide tray for analysis. Two 50 
separate NMR imaging fluids were tested, water with a self 
diffusion constant of Do = 2×10-9 m2 s-1 and a silicone oil with 
Do = 1.9×10-10 m2 s-1. 
Fig. 2 Colour-coded MRI (RARE sequence) images (black circles have 
been added to highlight the boundaries of the alternatively SPIO-labelled 55 
spots) of the same water saturated system imaged with increasing echo 
time: (a) TE/TEeff = 10 ms/635 ms, ( b) TE/TEeff = 20 ms/1.27 s, (c)  
TE/TEeff = 30 ms/1.905 s). The lower plot (d) shows the line profiles for 
each of the three images at horizontal coordinates, x = 0.45 cm. All data 
were scaled so as to reach the same maximum pixel intensity. 60 
 A Bruker® 2.35 T small-bore BIOSPEC MRI scanner was 
used to image the fluid-saturated arrays using RARE scan 
protocols.21 This allowed a complete set of MR images of a 
sample volume to be obtained and 2D slices corresponding to 
a given array within those images to be extracted.  65 
 Results illustrated in Fig. 1 and 2 show that DNA 
hybridisation can be identified on spots with negative 
contrast. This loss of signal is caused by exploiting the T2* 
contrast, as is demonstrated by the two independent 
observations that using a fluid with higher diffusion 70 
(a)     (b)      (c) 
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coefficient (Fig. 1) or a longer echo time (Fig. 2) produces 
better contrast. From Fig. 2, the ratio of NMR signals coming 
from two different locations, one without and one with 
immobilised SPIO, is seen to be as high as 14 for TE = 30 ms, 
whilst the signal to noise ratio is approximately 10. The 5 
definition of the spots is improved when using water (Fig 1a), 
which has a molecular self-diffusion coefficient ten times 
higher than that of the oil used (Fig 1a).  
 The line profiles of three experiments, wherein the TE of 
the sample in water is increased from 10 to 30 ms (Fig. 2), at 10 
x = 0.45 cm, demonstrates that there is an enhanced contrast 
with longer TE times. This is also clearly evident, by simply 
observing the relative contrast differences, by eye, in the three 
images of the same array, when all other MRI parameters 
remain constant (16 averages, slice thickness = 0.7 mm, 15 
imaging time = 61 s, RARE factor = number of lines = 128). 
Increasing TE improves contrast, at the cost of loss of spatial 
resolution and SNR. Spatial resolution is also limited by the 
spatial extent of the magnetic perturbation, an effect which we 
have not quantitatively explored. 20 
 In all measurements the selected slice was set up so as to 
capture the signal coming from the fluid residing just above 
the array. For all images the colour-coding spans all signal 
intensities (in arbitrary units) found in the data in order to 
display the genuine contrast. Signal variations on all MRI 25 
images are also seen on a large length scale due to drop in the 
B1 homogeneity of the scanner’s resonator and due to the 
selected slice being slightly off-horizontality (the 
horizontality of the array was set by using a spirit level). 
 In summary NMR microscopy has been demonstrated to be 30 
a suitable technique for microarray analysis when using 
magnetic particles as labelling compounds. Binding has been 
identified by the local signal intensity modulated by the local 
relaxation times. At high polarising field strength, the SPIO’s 
effect within NMR is mostly found as a perturbation on the 35 
magnetic field surrounding the SPIO, resulting in signal loss. 
This effect can be modulated with outstanding flexibility by 
altering the nature and density of the SPIO, by changing the 
polarising field strength, the sequence echo time, the MRI 
sequence itself, and it is also dependent on the chosen NMR 40 
imaging fluid. At low field strength, SPIO can also be used 
for enhancing the measured NMR fluid signal by lowering the 
local T1 value.22 The method we demonstrated does not 
require optical transparency of the sample, thereby offering 
potential measurements on high density porous spots. It could 45 
work with NMR gases, including hyperpolarised ones. 
 MRI was also found to be a suitable technique for the 
simultaneous analyses of multiple stacked slides (3D arrays) 
for high density thoughput. We are working to further 
optimise the resolution of these array systems to sub 50 
millimetric spots which can be resolved in less than one 
minute.†  
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 Electronic Supplementary Information (ESI) available: Preliminary  
experiments on millimetric spots have been identified within an imaging 
time below one minute. The binding strategies for the DNA array on a 5 




 Complementary 5’ to 3’ and 3’ to 5’ oligonucleotide sequences (5-
CTCCTGAGGAGAAGGTCTGCTGGAC-3 and 5-10 
GTCCAGCAGACCTTCTCCTCAGGAG-3) were modified with the 
incorporation of thiol (-SH) groups linked to the 5’ end by a 6-carbon 
spacer (Sigma-Genosys) and subsequently reconstituted in water to a 
concentration of 100 µM. Trityl groups were removed by incubation with 
0.04 M DDT in 0.17 M phosphate buffer (pH 8.0) at room temperature 15 
for 16 hours. DTT and thiol by- products were removed using NAP-10 
columns, following the manufacturer’s protocol (GE healthcare). Finally 
the oligonucleotide fractions were verified by taking readings at 260 nm, 
pooled and diluted to stock aliquots of 60 µM. 
 20 
